Owlstone Medical Ltd - Product Pipeline Analysis, 2018 Update

Published by Global Data on 27th December 2018 | Ref: 1127963 | This Report Is In Stock

$750 | Single User
$1500 | Site License
$2250 | Enterprise License
$750 | Single User
$1500 | Site License
$2250 | Enterprise License



Owlstone Medical Ltd (Owlstone Medical), formerly Tiger Dawn Ltd, is a diagnostic company. The company develops and commercializes breathalyzers for use in clinical diagnostics and precision medicines. It offers FAIMS Technology for medical applications; Lonestar for disease biomarker detection; and ATLAS for volatile organic compounds sampling from clinical sample. Owlstone Medical provides UltraFAIMS for enhanced mass spectrometry for medical research; simulated human breath (SiHuB) products; CASPER that provides clean air supply for portable use in clinics; and respiration collector for in vitro analysis (ReCIVA) breath sampler. The company’s products are used in applications such as lung cancer, asthma, tuberculosis, bowel (colorectal) cancer, coeliac disease and irritable bowel syndrome, inflammatory bowel disease, bile acid diarrhea, gastrointestinal toxicity, drug metabolites in urine, and propofol detection and monitoring. It operates offices in Cambridge and London, the UK. Owlstone Medical is headquartered in London, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Owlstone Medical Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Owlstone Medical Ltd Company Overview 5

Owlstone Medical Ltd Company Snapshot 5

Owlstone Medical Ltd Pipeline Products and Ongoing Clinical Trials Overview 5

Owlstone Medical Ltd – Pipeline Analysis Overview 8

Owlstone Medical Ltd - Key Facts 8

Owlstone Medical Ltd - Major Products and Services 9

Owlstone Medical Ltd Pipeline Products by Development Stage 10

Owlstone Medical Ltd Pipeline Products Overview 12

Breathalyzer - Bladder Cancer 12

Breathalyzer - Bladder Cancer Product Overview 12

Breathalyzer - Brain Tumor 13

Breathalyzer - Brain Tumor Product Overview 13

Breathalyzer - Breast Cancer 14

Breathalyzer - Breast Cancer Product Overview 14

Breathalyzer - Colorectal Cancer 15

Breathalyzer - Colorectal Cancer Product Overview 15

Breathalyzer - Head And Neck Cancer 16

Breathalyzer - Head And Neck Cancer Product Overview 16

Breathalyzer - Kidney Cancer 17

Breathalyzer - Kidney Cancer Product Overview 17

Breathalyzer - Lung Cancer 18

Breathalyzer - Lung Cancer Product Overview 18

Breathalyzer - Oesophageal Cancer 19

Breathalyzer - Oesophageal Cancer Product Overview 19

Breathalyzer - Pancreatic Cancer 20

Breathalyzer - Pancreatic Cancer Product Overview 20

Breathalyzer - Prostate Cancer 21

Breathalyzer - Prostate Cancer Product Overview 21

STRATA Breath Test 22

STRATA Breath Test Product Overview 22

Owlstone Medical Ltd - Key Competitors 23

Owlstone Medical Ltd - Key Employees 24

Owlstone Medical Ltd - Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

Owlstone Medical Ltd, Recent Developments 26

Jul 19, 2018: Owlstone Medical appoints five leading experts to scientific advisory board 26

Jun 27, 2018: Breath Biopsy platform scoops the UK’s most prestigious award for engineering innovation 28

Apr 09, 2018: Owlstone Medical provides Breath Biopsy Services to AstraZeneca to study disease drivers in Asthma and COPD 29

Mar 28, 2018: Owlstone Medical Launches Breath Biopsy Kits 29

Jan 26, 2018: Owlstone Medical's Breath Biopsy Wins Global IPF Catalyst Challenge 30

Dec 05, 2017: Owlstone Medical Selected to Participate at Upcoming Cavendish Global Health Impact Forum 30

Jul 10, 2017: Owlstone Medical and Cancer Research UK (CRUK) Initiate Pan Cancer Clinical Trial to Evaluate Breath Biopsy for Early Detection of Disease 31

May 23, 2017: Owlstone Medical Establishes Scientific Advisory Board with Appointment of Professor Sir Bruce Ponder 32

Apr 19, 2017: Owlstone Medical and Mayo Clinic Collaborate to Develop Pre-Endoscopic Test to Improve Effectiveness of Colonoscopy 32

Mar 24, 2017: Owlstone Medical Wins Business Innovation Award for Breath Biopsy Technology 33

Appendix 34

Methodology 34

About GlobalData 37

Contact Us 37

Disclaimer 37

Additional Details


Global Data

Publisher Information


1127963 | GDME2540900PD

Number of Pages


Report Format


This report is published by Global Data

Download Free Report Summary PDF

Owlstone Medical Ltd - Product Pipeline Analysis, 2018 Update [Updated: 27-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types


Buy now using our secure payment system.